Patents by Inventor Corey Bloom

Corey Bloom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
    Patent number: 11395818
    Abstract: Provided herein are low impurity compositions comprising a compound represented by Formula (I): which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFR? kinases, and oncogenic forms thereof.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: July 26, 2022
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
  • Oral formulations of belinostat
    Patent number: 11266614
    Abstract: The present application concerns new formulations of belinostat suitable for oral administration, their process of preparation, the pharmaceutical compositions comprising said formulations and their uses thereof.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: March 8, 2022
    Assignee: ONXEO
    Inventors: Perrine Pivette, Caroline Lemarchand, Ian Yates, Corey Bloom
  • AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20220031677
    Abstract: Provided herein is an amorphous compound represented by Formula (I): and compositions thereof, which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFR? kinases, and oncogenic forms thereof.
    Type: Application
    Filed: October 18, 2021
    Publication date: February 3, 2022
    Inventors: Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
  • Amorphous kinase inhibitor formulations and methods of use thereof
    Patent number: 11185535
    Abstract: Provided herein is an amorphous compound represented by Formula (I): and compositions thereof, which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFR? kinases, and oncogenic forms thereof.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: November 30, 2021
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
  • AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20210196692
    Abstract: Provided herein is an amorphous compound represented by Formula (I): and compositions thereof, which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFR? kinases, and oncogenic forms thereof.
    Type: Application
    Filed: February 19, 2021
    Publication date: July 1, 2021
    Inventors: Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
  • COMPOSITIONS OF 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHENYL)-3-PHENYLUREA
    Publication number: 20210196693
    Abstract: Provided herein are low impurity compositions comprising a compound represented by Formula (I): which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFR? kinases, and oncogenic forms thereof.
    Type: Application
    Filed: February 19, 2021
    Publication date: July 1, 2021
    Inventors: Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
  • NEW ORAL FORMULATIONS OF BELINOSTAT
    Publication number: 20200155485
    Abstract: The present application concerns new formulations of belinostat suitable for oral administration, their process of preparation, the pharmaceutical compositions comprising said formulations and their uses thereof.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 21, 2020
    Inventors: Perrine PIVETTE, Caroline LEMARCHAND, Ian YATES, Corey BLOOM
  • COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES
    Publication number: 20200009118
    Abstract: In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine, an ABCG2 inhibitor and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine and an ABCG2 inhibitor.
    Type: Application
    Filed: February 7, 2019
    Publication date: January 9, 2020
    Applicant: Glialogix, Inc.
    Inventors: Thaddeus Cromwell Reeder, Mark W. Moore, David K. Lyon, Casey K. Jager, Doug Lorenz, Corey Bloom, Kimberley Shepard
  • Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same
    Publication number: 20190209556
    Abstract: This disclosure provides, among other things, compositions comprising quantities of oltipraz crystals, as well as method of making such compositions, and method of treating patients using such compositions.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 11, 2019
    Inventors: Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Bret Berner, Michael Edward Grass, Casey Keith Jager, Jay Corey Bloom, Mark Joseph Kastantin
  • Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same
    Publication number: 20190209557
    Abstract: This disclosure provides, among other things, compositions comprising quantities of oltipraz crystals, as well as method of making such compositions, and method of treating patients using such compositions. Taste-modified compositions also are provided.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 11, 2019
    Inventors: Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Bret Berner, Michael Edward Grass, Casey Keith Jager, Jay Corey Bloom, Mark Joseph Kastantin, Romain Bachelard
  • COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES
    Publication number: 20180110760
    Abstract: In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine, an ABCG2 inhibitor and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine and an ABCG2 inhibitor.
    Type: Application
    Filed: October 20, 2017
    Publication date: April 26, 2018
    Applicant: Glialogix, Inc.
    Inventors: Thaddeus Cromwell Reeder, Mark W. Moore, David K. Lyon, Casey K. Jager, Doug Lorenz, Corey Bloom, Kimberly Shepard
  • Low work function metal complexes and uses thereof
    Publication number: 20050231100
    Abstract: The present invention provides conductive metal-ligand coordination complexes that are useful in a variety of electronic devices. For example, such complexes are useful in organic light emitting devices composed of one or more layers of organic material between two conductors. The use of metal-ligand coordination complexes of the present invention as the cathode, replaces the more typically employed reactive metals, which function as the electron injecting contact, and provides for improved or longer-lived devices.
    Type: Application
    Filed: August 12, 2003
    Publication date: October 20, 2005
    Applicant: Colorado State University Research
    Inventors: C Elliott, Corey Bloom